Skip to main content
Clinical Trials/NCT05443958
NCT05443958
Recruiting
Not Applicable

The Role of IEEG in the Localization of EZ and Its Relationship With Prognosis

Second Affiliated Hospital, School of Medicine, Zhejiang University1 site in 1 country120 target enrollmentJuly 1, 2022
ConditionsEpilepsy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epilepsy
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment
120
Locations
1
Primary Endpoint
Comparison of clinical data and IEEG characteristics in the seizure-free and not seizure-free groups
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The mechanism of epilepsy pathogenesis is complex and not fully defined, and about 20-30% of patients with seizures that cannot be completely controlled by drugs become drug-resistant epilepsy. For focal drug-resistant epilepsy, surgical removal of the epileptogenic zone can control seizures, but the overall seizure-free rate in the long term after surgery is 60-70%, and the results are still not satisfactory. Accurate assessment of the location and extent of the epileptogenic zone and its adequate excision are prerequisites for the success or failure of surgery. Intracranial EEG (iEEG) has been shown to be the most accurate method for determining the location and boundaries of the epileptogenic zone. It can selectively record the local cortical electrical activity through intracranial electrodes and achieve high temporal resolution for long-range recording, reliably reflecting the continuous dynamic changes of EEG during interictal and ictal periods. The in-depth analysis of iEEG can improve the efficacy of epilepsy surgery and provide important information to reveal the pathogenesis of epilepsy.

Registry
clinicaltrials.gov
Start Date
July 1, 2022
End Date
December 30, 2025
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Complete clinical history;
  • IEEG monitoring at least one habitual seizure;
  • Follow up for at least 1 year;
  • Signed informed consent.

Exclusion Criteria

  • Habitual seizures were not found in iEEG monitoring;
  • No operation was performed;
  • Lost to follow-up for various reasons within 1 year after surgery.

Outcomes

Primary Outcomes

Comparison of clinical data and IEEG characteristics in the seizure-free and not seizure-free groups

Time Frame: 1-2 years

Compare two groups of patients with clinical data (sex, age at onset, age at surgery, epilepsy duration, seizure lateralization/localization, MRI findings, Pathology) and EEG characteristics (contact number, EEG onset pattern, IEEG power of each frequency band, functional connectivity of each frequency band).

Study Sites (1)

Loading locations...

Similar Trials